1. Volume 58, Issue 2, Pages 684-690 (August 2000)
Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy 
Nobuyuki Banba, Tsutomu Nakamura, Michiko Matsumura, Hisamoto Kuroda, Yoshiyuki Hattori, Kikuo Kasai 
Kidney International 
Volume 58, Issue 2, Pages (August 2000)
DOI: /j x
Copyright © 2000 International Society of Nephrology Terms and Conditions

2. Figure 1
Comparison of urinary and serum monocyte chemoattractant protein-1 (MCP-1) levels (A and B) in the control group (C) and diabetic subgroups (D0, D1, and D2), and correlations of urinary levels of MCP-1 with urinary levels of albumin (Alb; C) and with serum levels of glycated albumin (Gly-Alb; D) in all subjects. After log-transformation (base 10) of urinary values of MCP-1 and Alb, a comparison was performed using Scheffe's post hoc test after one-way analysis of variance (ANOVA). The data represented are the mean ± SD. Abbreviations are: C, controls; D0, diabetics with normoalbuminuria; D1, diabetics with microalbuminuria; D2, diabetics with macroalbuminuria. ⋆⋆P < 0.01; ⋆⋆⋆⋆P < vs. C; ★P < 0.05; ★★★★P < vs. D0. Simple regression analyses were performed using the values in all subjects.
Kidney International  , DOI: ( /j x)
Copyright © 2000 International Society of Nephrology Terms and Conditions

3. Figure 2
Time-course changes in the abundance of mRNA levels and the amounts of MCP-1 produced by mesangial cells. Mesangial cells were incubated in 60 mm dish in the 0.5% FBS containing medium with normoglucose (•; NG, 5.5 mmol/L) with or without human serum Alb (○; 1 mg/mL) or Gly-Alb (□; 1 mg/mL). Data are the mean of two dishes. (Inset) The abundance of mRNAs for MCP-1 and GAPDH as reference at indicated times was evaluated by RT-PCR.
Kidney International  , DOI: ( /j x)
Copyright © 2000 International Society of Nephrology Terms and Conditions

4. Figure 3
Dose-dependent stimulation of MCP-1 gene and protein expression by Gly-Alb in cultured mesangial cells. Mesangial cells in 48-well plate or 60 mm dish were incubated with graded doses of Alb (•) or Gly-Alb (○; 0.25 to 4 mg/mL) in 0.5% FBS containing medium with normoglucose (NG, 5.5 mmol/L). The secreted amounts of MCP-1 during 48-hour incubation are represented as the mean ± SD of four individual wells. (Inset) The abundance of mRNAs for MCP-1 and GAPDH as reference at indicated times was evaluated by RT-PCR.
Kidney International  , DOI: ( /j x)
Copyright © 2000 International Society of Nephrology Terms and Conditions

5. Figure 4
Effects of Gly-Alb, high concentration of glucose (HG) and the combination of both on the gene and protein expression of MCP-1 by mesangial cells. Mesangial cells in a 48-well plate or a 60 mm dish were incubated with Alb (1 mg/mL) or Gly-Alb (1 mg/mL) in 0.5% FBS containing medium with normoglucose (NG, 5.5 mmol/L) or high glucose (HG, 26.5 mmol/L). The secreted amounts of MCP-1 during 48-hour incubation are represented as the mean ± SD of four individual wells. cP < vs. NG in the respective condition; *P < 0.05; ***P < vs. basal in the respective condition; (Inset) The abundance of mRNAs for MCP-1 and GAPDH as reference at four hours was evaluated by RT-PCR.
Kidney International  , DOI: ( /j x)
Copyright © 2000 International Society of Nephrology Terms and Conditions

6. Figure 5
Effects of inhibitors of NF-κB, AP-1, or general transcription on the gene and protein expression of MCP-1 in mesangial cells. Mesangial cells in 48-well plate or 60 mm dish were incubated with Alb (1 mg/mL) or Gly-Alb (1 mg/mL) in 0.5% FBS containing medium with normoglucose (NG, 5.5 mmol/L) or high glucose (HG, 26.5 mmol/L) in the presence or absence of pyrrolidine dithiocarbamate (PDTC, 50 μmol/L), curcumin (25 μmol/L), or actinomycin D (Act D, 1 μg/mL). The secreted amounts of MCP-1 during 48-hour incubation are represented as the mean ± SD of four individual wells. aP < 0.05, cP < vs. NG in the respective condition. (Inset) The abundance of mRNAs for MCP-1 and GAPDH as reference at four hours was evaluated by RT-PCR.
Kidney International  , DOI: ( /j x)
Copyright © 2000 International Society of Nephrology Terms and Conditions